Overview and Scope
Protein inhibitors refer to compounds that interfere with the steps directly involved in the production of new proteins in cells. Protein inhibitors operate at the ribosome level, benefiting from the significant variations between prokaryotic and eukaryotic ribosome architectures.
Sizing and Forecast
The protein inhibitors market size has grown strongly in recent years. It will grow from $80.99 billion in 2023 to $88.74 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to drug discovery, drug development, cancer treatment, regulatory approvals.
The protein inhibitors market size is expected to see strongly grown in the next few years. It will grow to $125.26 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to precision medicine, immunotherapy, drug combinations, aging population. Major trends in the forecast period include data sharing and collaboration, sustainability and esg, personalized medicine, adaptive clinical trials.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/protein-inhibitor-global-market-report
Segmentation & Regional Insights
The protein inhibitors market covered in this report is segmented –
1) By Product: Protein Kinase Inhibitors, Monoclonal Antibody, Other Products
2) By Application: Oncology, Inflamatory Diseases, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies
North America was the largest region in the protein inhibitors market in 2023. The regions covered in the protein inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3429&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of chronic diseases is predicted to contribute to the growth of the protein inhibitors market over the forecast period. Chronic diseases such as cancer, cardiovascular diseases, and autoimmune diseases are becoming more prevalent. For instance, in May 2022, according to the World Health Organization, chronic diseases are expected to become the seventh leading cause of death globally by the end of 2030.In the USA, the number reached 157 million in 2020, with 87 million people having multiple conditions. Protein inhibitors are used for the treatment of these diseases attributing to fewer adverse effects and higher efficacy. Therefore, an increasing number of people with chronic diseases are anticipated to propel the demand for growth of the protein inhibitors market.
Key Industry Players
Major companies operating in the protein inhibitors market include Bayer AG, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Apotex Inc., Novartis International AG, GlaxoSmithKline plc, Pfizer Inc., Boehringer Ingelheim International GmbH, Abbott Laboratories, Amgen Inc., Baxter International Inc., Merck & Co. Inc., Interprotein Corporation, AbbVie Inc., Bristol Myers Squibb Company, Galapagos NV, Priovant Therapeutics Inc., Tempus Labs Inc., ReCode Therapeutics Inc., Satellite Bio Inc., Ambagon Therapeutics Inc., Biogen Inc., Eli Lilly and Company, Gilead Sciences Inc., Johnson & Johnson, Regeneron Pharmaceuticals Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Vertex Pharmaceuticals Inc., Lonza Group AG, Catalent Inc., Thermo Fisher Scientific Inc., Charles River Laboratories International Inc., WuXi AppTec Co. Ltd.
The protein inhibitors market report table of contents includes:
1. Executive Summary
2. Protein Inhibitors Market Characteristics
3. Protein Inhibitors Market Trends And Strategies
4. Protein Inhibitors Market – Macro Economic Scenario
5. Global Protein Inhibitors Market Size and Growth
.
.
.
31. Global Protein Inhibitors Market Competitive Benchmarking
32. Global Protein Inhibitors Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Protein Inhibitors Market
34. Protein Inhibitors Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
